EP2517584B1 - Composite filter comprising biological composition - Google Patents
Composite filter comprising biological composition Download PDFInfo
- Publication number
- EP2517584B1 EP2517584B1 EP10838536.0A EP10838536A EP2517584B1 EP 2517584 B1 EP2517584 B1 EP 2517584B1 EP 10838536 A EP10838536 A EP 10838536A EP 2517584 B1 EP2517584 B1 EP 2517584B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- biological composition
- composite filter
- leaf extract
- ginkgo leaf
- tow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 60
- 239000002131 composite material Substances 0.000 title claims description 29
- 235000019504 cigarettes Nutrition 0.000 claims description 34
- NVJHHSJKESILSZ-UHFFFAOYSA-N [Co].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 Chemical compound [Co].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 NVJHHSJKESILSZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 12
- 230000009977 dual effect Effects 0.000 claims description 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
- 239000000779 smoke Substances 0.000 description 20
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 13
- 230000003078 antioxidant effect Effects 0.000 description 13
- 229930003935 flavonoid Natural products 0.000 description 13
- 150000002215 flavonoids Chemical class 0.000 description 13
- 235000017173 flavonoids Nutrition 0.000 description 13
- 150000003254 radicals Chemical class 0.000 description 13
- 230000000391 smoking effect Effects 0.000 description 13
- 150000004032 porphyrins Chemical class 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000003993 interaction Effects 0.000 description 10
- -1 polypropylene Polymers 0.000 description 9
- BXYPVKMROLGXJI-JTQLQIEISA-N 3-[(2s)-1-nitrosopiperidin-2-yl]pyridine Chemical compound O=NN1CCCC[C@H]1C1=CC=CN=C1 BXYPVKMROLGXJI-JTQLQIEISA-N 0.000 description 8
- FLAQQSHRLBFIEZ-UHFFFAOYSA-N N-Methyl-N-nitroso-4-oxo-4-(3-pyridyl)butyl amine Chemical compound O=NN(C)CCCC(=O)C1=CC=CN=C1 FLAQQSHRLBFIEZ-UHFFFAOYSA-N 0.000 description 8
- XKABJYQDMJTNGQ-VIFPVBQESA-N n-nitrosonornicotine Chemical compound O=NN1CCC[C@H]1C1=CC=CN=C1 XKABJYQDMJTNGQ-VIFPVBQESA-N 0.000 description 8
- 241000208125 Nicotiana Species 0.000 description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000005526 G1 to G0 transition Effects 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 231100000111 LD50 Toxicity 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 150000002596 lactones Chemical class 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 238000010953 Ames test Methods 0.000 description 3
- 231100000039 Ames test Toxicity 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 231100000636 lethal dose Toxicity 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 231100000299 mutagenicity Toxicity 0.000 description 2
- 230000007886 mutagenicity Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- ZJOFAFWTOKDIFH-UHFFFAOYSA-N 3-(1-nitroso-3,6-dihydro-2h-pyridin-2-yl)pyridine Chemical compound O=NN1CC=CCC1C1=CC=CN=C1 ZJOFAFWTOKDIFH-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000218628 Ginkgo Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001723 carbon free-radicals Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 150000004033 porphyrin derivatives Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000004835 semi-empirical calculation Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000007666 subchronic toxicity Effects 0.000 description 1
- 231100000195 subchronic toxicity Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
Definitions
- This invention involves a type of composite filter tips containing biological composition, more specifically, the application of biological composition composed of cobalt porphyrin and ginkgo leaf extract to the filter tip, which belongs to the processing technology of filter tip additive and filter tip.
- the filter tip is used for filtering the harmful substances in smoke, with the tar removal rate of about 35%.
- the existing fiber filter rod consists mainly of either acetate tow or polypropylene tow, and its filtration efficiency depends on molecular structure and physicochemical properties. The above-mentioned two materials, limited by the structure and physicochemical properties, have defects in filtration efficiency.
- the acetate tow carries negative charge, while lots of particles in smoke (about 2 ⁇ 10 9 negative charge particles per 1ml smoke) also carry the negative charge.
- part polar structure in the tow has a certain affinity for only the highly polar matters containing oxygen atoms, such as aldehyde ketone and lactone (carboxyl compounds) as well as furan and phenolic compound (heterocyclic compounds), and thus filters selectively the matters.
- the acetate tow has a low absorbing capacity for harmful carbon radical, aromatic hydrocarbon, propylene (lowly polar compound) and trace metal element in the smoke.
- the polypropylene tow is a high molecular saturated alkane compound and free from the negative charge group; its molecular structure is stable, and its physicochemical properties are inert; its hydrophobic group is of the nonpolar structure, and there is no polar structure with a strong affinity for polar smoke components; change of pressure drop will not impact on selective filtration of the polar smoke components. Accordingly, the polypropylene tow has low remove efficiency for polar components and low-boiling spicy miscellaneous gas molecules in the smoke.
- the smoke contains many harmful ingredients, especially possibly cancerogenic free radical, condensed aromatics and tobacco specific nitrosamine, all of which cannot be removed effectively by the above traditional filter tips.
- a type of filter tips with strengthened functions is needed. Adding the composition to filter tip aims to not only remove selectively the harmful ingredients in smoke, but also make the harmless flavor components in smoke pass smoothly the filter tip. In addition, such new filter tip also requires convenient production, low production cost and easy realization of industrialization.
- the porphyrins are of unique structure. Specifically, its molecule is rigid and has large face; position and direction of its edge functional group can be controlled so that molecular size, molecularity, functional group and chiral isomer can be identified effectively.
- the porphyrins have been applied in chromatographic fractionation analysis, sensor, artificial enzyme analysis and receptor building in the field of analytical chemistry.
- stationary phase of porphyrin derivatives has been successfully applied in HPLC and CE etc. Kibbey etc.
- the ginkgo leaf extract As Chinese herbal medicine, the ginkgo leaf extract has been used for thousands of years in China. The internationally recognized ginkgo leaf extract contains over 24% flavonoid and over 6% lactone. The research shows that the main active constituent with antioxidative effect in ginkgo leaf extract is the flavonoid and the lactone has no obvious antioxidative effect ( Mou Lingli etc., Chemical Constituents in Ginkgo Leaf and Their Antioxidative Activity, Chinese Journal of Natural Medicines, 2008, 6(1): 26-29 .), and that the reductive hydroxyl (-OH) functional group in the molecule can play a direct role in antioxidative effect.
- Quercetin in flavonoid serving as a hydrogen atom donor, can interdict and terminate the free radical chain reaction, remove directly free radicals and hydrogen peroxide, antagonize effectively the destroy of free radicals on unsaturated fatty acid, reduce content of lipidic peroxide, and enhance activity of the superoxide dismutase ( Li Yuhua etc., Action of Ginkgo Leaf Extract [J]. Chinese Health Care, 2008, 16(11):529 .).
- the chemiluminescent method determines the O 2 ⁇ removal effect by flavonoid.
- the research on relations between its structure and O 2 ⁇ removal activity proves that 4'-OH and 2, 3 double bond are the main activity parts of removing O 2 ⁇ ( Zou Yaohong etc., The Research on Property of Flavonoid to Remove Active Oxygen Free Radical [J].
- Antioxidative activity of flavonoids can be improved by means of changing hydroxyl substitute, making distribution of electron spin density for semiquinone free radical more uniform, increasing the amount of phenolic hydroxyl in flavonoids and of intramolecular hydrogen bonds by chemical modification.
- porphyrins with unique structure are characterized by good selectivity and separating property when condensed aromatics and Fuller hydrocarbon etc. are determined by solid phase of HPLC; the ginkgo leaf extract has good antioxidative activity. Therefore, the composition of porphyrins and ginkgo leaf extract, if used in the filter tip, can remove effectively the harmful ingredients, and thus the filter tip with strengthened functions comes into being.
- WO 03/053179 A1 discloses cigarette filters containing lipophile flavonoids and/or tocopherols and tocotrienols.
- This invention aims to provide a type of filter tips with high removal efficiency of harmful substances in smoke, so as to reduce smoking harm on human body.
- the carrier adhering to the biological composition is added to the tow filter rod to make the composite filter tip.
- the biological composition is composed of cobalt porphyrin and ginkgo leaf extract.
- a type of composite filter tips containing biological composition which contains a biological composition adhering to the carrier, and which is added to the tow filter rod when the rod is made.
- the biological composition consists of cobalt porphyrin and ginkgo leaf extract. 2.
- it is the dual composite filter which is made from the tow filter rod with biological composition and that without biological composition.
- the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1 ⁇ 80; ratio of mass of the biological composition to the carrier is 0.1 ⁇ 5.0 ⁇ ; the addition of the carrier with biological composition in the tow filter rod is 3-30mg/cigarette.
- the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1 ⁇ 50.
- the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1 ⁇ 10. 6.
- the methods of preparing the composite filter tip containing biological composition including the following steps:
- Figure 2 is the spectrogram on interaction of porphyrins and TSNAs, (A), (B), (C) and (D) are the spectrogram on interaction with NNN, NAB, NNK and NAT respectively, of which B-H and B-L are spectrum curves for NNN, NAB, NNK and NAT with increasing concentration in cobalt porphyrin.
- Figure 3 is the structural representation of dual composite filter.
- the dual composite filter in this invention consists of tow filter rod 1 (the biological composition adheres to the carrier, and then such carrier is added evenly to the tow filter rod when the rod is made.), tow filter rod without biological composition 2, inner coil paper 3 and outer coil paper 4, and its main characteristic is that the carrier with biological composition is added evenly to the tow filter rod.
- mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1 ⁇ 80, 1:1 ⁇ 50 (better), 1:1 ⁇ 30 (much better), or 1:1 ⁇ 10 (best).
- the ratio of biological composition to ethanol is 1g biological composition: 10-100ml ethanol, 1g biological composition: 10-50ml ethanol (better), or 1g biological composition: 10-20ml ethanol (best).
- mass ratio of polyvinylpyrrolidone to biological composition is 1:1 ⁇ 50, 1:1 ⁇ 20 (better), or 1:1-10 (best).
- the carrier is active carbon, green plant particle and silicate.
- the ratio of mass of the biological composition to the carrier is 0.1 ⁇ 5.0 ⁇ .
- the addition of the carrier with biological composition added to the tow filter rod is 3-30mg/cigarette.
- the adding method is that the carrier with biological composition falls to the tow filter rod so as to control quantity of the barrier.
- the tow filter rod may be acetate tow, polypropylene tow, or made of other materials.
- the carrier with biological composition is evenly added when the tow filter rod is made.
- the tow filter rod 1 with biological composition and tow filter rod 2 without biological composition respectively are made by inner coil paper 3.
- two rods are made into the dual composite filter by outer coil paper 4.
- the dual composite filter integrates by cork with the cut tobacco wrapped by coil paper on cigarette maker, and the rod 1 is placed between the rod 2 and cut tobacco.
- Cobalt porphyrin used in this invention at the content of 96%, is purchased from ALFA, while ginkgo leaf extract, containing 24% flavone and 6% lactone, is purchased from Ningbo Liwah Pharmaceutical CO.,LTD.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
Description
- This invention involves a type of composite filter tips containing biological composition, more specifically, the application of biological composition composed of cobalt porphyrin and ginkgo leaf extract to the filter tip, which belongs to the processing technology of filter tip additive and filter tip.
- The filter tip is used for filtering the harmful substances in smoke, with the tar removal rate of about 35%. The existing fiber filter rod consists mainly of either acetate tow or polypropylene tow, and its filtration efficiency depends on molecular structure and physicochemical properties. The above-mentioned two materials, limited by the structure and physicochemical properties, have defects in filtration efficiency. The acetate tow carries negative charge, while lots of particles in smoke (about 2×109 negative charge particles per 1ml smoke) also carry the negative charge. As the same charges repel each other, such filter tip removes particulate matter in smoke by means of mechanical restriction and diffusion deposition; as a result of no active group, part polar structure in the tow has a certain affinity for only the highly polar matters containing oxygen atoms, such as aldehyde ketone and lactone (carboxyl compounds) as well as furan and phenolic compound (heterocyclic compounds), and thus filters selectively the matters. However, the acetate tow has a low absorbing capacity for harmful carbon radical, aromatic hydrocarbon, propylene (lowly polar compound) and trace metal element in the smoke. Furthermore, the polypropylene tow is a high molecular saturated alkane compound and free from the negative charge group; its molecular structure is stable, and its physicochemical properties are inert; its hydrophobic group is of the nonpolar structure, and there is no polar structure with a strong affinity for polar smoke components; change of pressure drop will not impact on selective filtration of the polar smoke components. Accordingly, the polypropylene tow has low remove efficiency for polar components and low-boiling spicy miscellaneous gas molecules in the smoke.
- It is well known that the smoke contains many harmful ingredients, especially possibly cancerogenic free radical, condensed aromatics and tobacco specific nitrosamine, all of which cannot be removed effectively by the above traditional filter tips.
- To this end, a type of filter tips with strengthened functions is needed. Adding the composition to filter tip aims to not only remove selectively the harmful ingredients in smoke, but also make the harmless flavor components in smoke pass smoothly the filter tip. In addition, such new filter tip also requires convenient production, low production cost and easy realization of industrialization.
- The porphyrins are of unique structure. Specifically, its molecule is rigid and has large face; position and direction of its edge functional group can be controlled so that molecular size, molecularity, functional group and chiral isomer can be identified effectively. At present, the porphyrins have been applied in chromatographic fractionation analysis, sensor, artificial enzyme analysis and receptor building in the field of analytical chemistry. For chromatographic analysis, stationary phase of porphyrin derivatives has been successfully applied in HPLC and CE etc. Kibbey etc. (Kibbey CE, Meyerhoff ME.Anal Chem,1993,65(17): 2189-2196.) synthesized for the first time the stationary phase of porphyrins, such as H2CPTPP, SnCPTPP and InCPTPP, which was used successfully for separation of PAHs. Then ProP-silica stationary phase (Xiao J, Kibbey CE, Coutant DE, et al. J Liq Chromatogr Rel Technol, 1996, 19:2901- 2932.) and MProP-silica stationary phase (Chen S, Meyerhoff ME.Anal Chem, 1998, 70(13): 2523- 2529.) were prepared to obtain better selectivity of molecular shape. Those stationary phases, more stable than stationary phase of fibers, are used for research of pre-enrichment carcinogenicity PAHs. The principle of good identifiability of PAHs by porphyrins is that PAHs rich in π electrons has strong π-π interaction with porphyrins. Such interaction has not only the face-to-face π-π interaction but also the face-to-edge one (Chen S, Fetzer JC, Meyerhoff ME. Fresenius J Anal Chem, 200 1(3-4):385-392. Yutaka S, Masaki M,Junichi O, et al.Anal Sci,1991, 7(5):805-806. Mifune M, Shimomura Y, Saito Y, et al.Bull Chem Soc Jpn,1998,71(8): 1825- 1829.).
- As Chinese herbal medicine, the ginkgo leaf extract has been used for thousands of years in China. The internationally recognized ginkgo leaf extract contains over 24% flavonoid and over 6% lactone. The research shows that the main active constituent with antioxidative effect in ginkgo leaf extract is the flavonoid and the lactone has no obvious antioxidative effect (Mou Lingli etc., Chemical Constituents in Ginkgo Leaf and Their Antioxidative Activity, Chinese Journal of Natural Medicines, 2008, 6(1): 26-29.), and that the reductive hydroxyl (-OH) functional group in the molecule can play a direct role in antioxidative effect. Quercetin in flavonoid, serving as a hydrogen atom donor, can interdict and terminate the free radical chain reaction, remove directly free radicals and hydrogen peroxide, antagonize effectively the destroy of free radicals on unsaturated fatty acid, reduce content of lipidic peroxide, and enhance activity of the superoxide dismutase (Li Yuhua etc., Action of Ginkgo Leaf Extract [J]. Chinese Health Care, 2008, 16(11):529.).
- The chemiluminescent method determines the O2· removal effect by flavonoid. The research on relations between its structure and O2· removal activity proves that 4'-OH and 2, 3 double bond are the main activity parts of removing O2· (Zou Yaohong etc., The Research on Property of Flavonoid to Remove Active Oxygen Free Radical [J]. Journal of Changshu College, 2001, 15(2):47-50.), and that 3', 4'- ortho dihydroxyl is the key structure of removing activity of free radicals while hydroxyls on the rest positions also play a role (Hu Chun etc., Research with Chemiluminescent Method on O2· and ·0H Removal by Flavonoid, Journal of Wuxi University of Light Industry, 1996, 15(3):194-198.).
- Structural factors of flavonoids for antioxidative activity are researched by the semi-empirical calculation methods of structural chemistry and quantum chemistry, and the relative results are described in the following. ① The energy Δ HOF required for forming semiquinone free radicals within molecule is low, and the free radical formed is stable, thus the antioxidative activity is strong.
② Uniform distribution of electron spin density is crucial for strong antioxidative activity. For the semiquinone free radical formed by flavone containing ortho-diphenol- hydroxyl, electron spin density is distributed evenly, and semiquinone group in molecule and hydrogen bond in molecule shaped by ortho phenolic hydroxyl make the system energy level decrease, so the antioxidative activity of flavonoid containing ortho-diphenol- hydroxyl is better than that containing meta-diphenol- hydroxyl. ③ Amount of phenolic hydroxyl in molecule and that of intramolecular H-bond are in positive correlation with antioxidative activity of the molecule, which contributes to an important factor of strong antioxidative activity of the flavonoid. (Zhao Jihong etc., Structural Factors of Flavonoids for Antioxidative Activity, Journal of North China University of Technology, 2001,13(1):36-44.) Antioxidative activity of flavonoids can be improved by means of changing hydroxyl substitute, making distribution of electron spin density for semiquinone free radical more uniform, increasing the amount of phenolic hydroxyl in flavonoids and of intramolecular hydrogen bonds by chemical modification. - The porphyrins with unique structure are characterized by good selectivity and separating property when condensed aromatics and Fuller hydrocarbon etc. are determined by solid phase of HPLC; the ginkgo leaf extract has good antioxidative activity. Therefore, the composition of porphyrins and ginkgo leaf extract, if used in the filter tip, can remove effectively the harmful ingredients, and thus the filter tip with strengthened functions comes into being.
-
WO 03/053179 A1 - This invention aims to provide a type of filter tips with high removal efficiency of harmful substances in smoke, so as to reduce smoking harm on human body.
- As for the invented filter tip, the carrier adhering to the biological composition is added to the tow filter rod to make the composite filter tip. The biological composition is composed of cobalt porphyrin and ginkgo leaf extract.
- This invention includes the following:
1. A type of composite filter tips containing biological composition, which contains a biological composition adhering to the carrier, and which is added to the tow filter rod when the rod is made. The biological composition consists of cobalt porphyrin and ginkgo leaf extract.
2. In detail: it is the dual composite filter which is made from the tow filter rod with biological composition and that without biological composition.
3. In detail: the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1~80; ratio of mass of the biological composition to the carrier is 0.1‰∼5.0‰; the addition of the carrier with biological composition in the tow filter rod is 3-30mg/cigarette.
4. In detail: the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼50.
5. In detail: the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼10.
6. The methods of preparing the composite filter tip containing biological composition, including the following steps: - (1) The biological composition of cobalt porphyrin and ginkgo leaf extract is prepared and then dissolved in ethanol. In addition, a polyvinylpyrrolidone is added to the ethanol solution containing biological composition and mixed up.
- (2) The mixture in Step (1) adheres to the carrier.
- (3) The carrier in Step (2) is added evenly when tow filter rod is made.
- (4) Then the tow filter rod with the composition and one without the composition are rolled with the inner coil paper respectively.
- (5) Finally, tow filter rods are made into the filter tip with outer coil paper on the composite filter tip maker.
- Test results of this invention and structural representation of filter tip are described in the following.
Figure 1 is the spectrogram on interaction of porphyrins and benzopyrene, Ksv = (5.27 ± 0.31) × 105.
Figure 2 is the spectrogram on interaction of porphyrins and TSNAs, (A), (B), (C) and (D) are the spectrogram on interaction with NNN, NAB, NNK and NAT respectively, of which B-H and B-L are spectrum curves for NNN, NAB, NNK and NAT with increasing concentration in cobalt porphyrin.
Figure 3 is the structural representation of dual composite filter. - This invention will be further specified with
Figure 3 in the following.
The dual composite filter in this invention consists of tow filter rod 1 (the biological composition adheres to the carrier, and then such carrier is added evenly to the tow filter rod when the rod is made.), tow filter rod withoutbiological composition 2,inner coil paper 3 andouter coil paper 4, and its main characteristic is that the carrier with biological composition is added evenly to the tow filter rod. - This invention is achieved in this way:
- A certain amount of cobalt porphyrin and ginkgo leaf extract is dissolved in 95% ethanol, and polyvinylpyrrolidone is added and mixed up. The solution in a certain proportion adheres to the carrier and then evenly added to the
tow filter rod 1 to get the dual composite filter. - In detail: mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1~80, 1:1~50 (better), 1:1~30 (much better), or 1:1∼10 (best).
- In detail: the ratio of biological composition to ethanol is 1g biological composition: 10-100ml ethanol, 1g biological composition: 10-50ml ethanol (better), or 1g biological composition: 10-20ml ethanol (best).
- In detail: mass ratio of polyvinylpyrrolidone to biological composition is 1:1∼50, 1:1∼20 (better), or 1:1-10 (best).
- In detail: the carrier is active carbon, green plant particle and silicate.
- In detail: the ratio of mass of the biological composition to the carrier is 0.1‰∼5.0‰.
- In detail: the addition of the carrier with biological composition added to the tow filter rod is 3-30mg/cigarette.
- In detail: the adding method is that the carrier with biological composition falls to the tow filter rod so as to control quantity of the barrier.
- In detail: the tow filter rod may be acetate tow, polypropylene tow, or made of other materials.
- In detail: the carrier with biological composition is evenly added when the tow filter rod is made. The
tow filter rod 1 with biological composition andtow filter rod 2 without biological composition respectively are made byinner coil paper 3. On the composite filter maker, two rods are made into the dual composite filter byouter coil paper 4. - Finally, the dual composite filter integrates by cork with the cut tobacco wrapped by coil paper on cigarette maker, and the
rod 1 is placed between therod 2 and cut tobacco. - Cobalt porphyrin used in this invention, at the content of 96%, is purchased from ALFA, while ginkgo leaf extract, containing 24% flavone and 6% lactone, is purchased from Ningbo Liwah Pharmaceutical CO.,LTD.
- The technical scheme described above and the specific processing steps listed in the following for preparing the dual composite filter are also applicable to the multiple composite filter made from many filter rods.
- Implementation Example: 5.0g cobalt porphyrin and 15.0g ginkgo leaf extract are weighed and dissolved in 400ml 95% ethanol, besides, added with 5g polyvinylpyrrolidone, mixed up, and which adheres to 40kg carrier. Then such carrier of 6mg/cigarette is added to the tow filter rod to make the dual composite filter, and the cigarette is made. Results of sensory evaluation, harmful ingredients test in smoke and biological test prove that the cigarette with the invented filter tip is characterized in consistent smoke well, reduced stimulation and tasty flavor; effect of releasing quantity decrease of harmful ingredients in smoke and biological test conform to the invention descriptions.
- The above implementation scheme has expounded this invention, but other implementation schemes are also possible. Consequently, nature and scope of the Claims should not be limited to descriptions of this implementation scheme in the present disclosure.
7. Application of the above composite filter tip containing biological composition to the cigarette The relative tests in the following:
a. Interaction of cobalt porphyrin and 3, 4-benzopyrene [a] is determined by fluorescence quenching method.
Polycyclic aromatic hydrocarbon always has characteristic photoluminescence excitation spectrum and fluorescence emission spectrum, so the interaction of cobalt porphyrin and 3, 4-benzopyrene [a] is determined by fluorescence quenching method. The result shows that, with the increase of cobalt porphyrin concentration, fluorescence intensity of 3, 4-benzopyrene [a] decreases, and fluorescence spectrum has red shift (see Attached
b. Interaction of cobalt porphyrin and tobacco specific nitrosamine is determined by ultraviolet spectrophotometry.
The porphyrins have the characteristic of ultraviolet absorption and characteristic absorption peak near 413nm, so the interaction of cobalt porphyrin and tobacco specific nitrosamine (TSNAs, NNN, NAB, NNK, NAT) is determined by ultraviolet spectrophotometry. The result shows that intensity of characteristic absorption peak (413nm) of porphyrins decreases after TSNAs is added, and the intensity will decrease gradually along with increasing concentration of TSNAs; new composite characteristic peak (438nm) appears and its intensity increases gradually along with increasing concentration of TSNAs; ultraviolet spectrum has red shift (see the Attached
c. The release of free radical, 3, 4-benzopyrene [a] and tobacco specific nitrosamine in smoke is determined.
For the blank control cigarette and the cigarette with the invented filter tip, releasing quantity of free radical, 3, 4-benzopyrene [a] and tobacco specific nitrosamine in smoke is determined, and filtration efficiency is calculated, see Table 1. According to the table, harmful ingredients in smoke of cigarette with the invented filter tip, compared with those in the blank control cigarette, reduce by 30.36%∼66.89%.
Gas-phase free radical (relative unit) | Solid-phase free radical (relative unit) | 4-benzopyrene [a] (ng/ cigarette) | NNK (ng/ cigarette) | NNN (ng/ cigarette) | NAB (ng/ cigarette) | NAT (ng/ cigarette) | |
No.1 | 8.73. | 8.31 | 14.50 | 5.50 | 9.09 | 1.07 | 11.74 |
No.2 | 6.08 | 5.60 | 9.80 | 3.30 | 3.01 | 0.43 | 6.53 |
Reduction rate (%) | 30.36 | 32.61 | 32.41 | 40.00 | 66.89 | 59.81 | 44.38 |
Note: No.1 is the cigarette without biological composition (blank control cigarette); No.2 is the cigarette with biological composition, and mass ratio of cobalt porphyrin to ginkgo leaf extract: 1:3. NNK:4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone;NNN:N-nitrosonornicotine;NAB: N-nitrosoanabasine; NAT: N-nitrosoanatabine |
d. Biological test
Toxicity of the blank control cigarette and the cigarette with the invented filter tip is tested, and the result proves that mutagenicity and toxicity of the latter are lower than those of the former.
(a) Salmonella typhimurium/ mammal microsome enzyme test (Ames test) Ames test results are listed in Table 2. Three doses from 100 to 500 in the table have inhibitory action, and the mutagenicity reduces.
Groups | Tested tar dose (µg/vessel) | Colony number of reverse mutation (number/vessel) | Inhibition rate (%) |
No.1 | 100 | 64.8±11.8 | |
300 | 83.2±12.0 | ||
500 | 107.2±9.7 | ||
No.2 | 100 | 42.8±10.0 | 49.66 |
300 | 53.2±9.8 | 47.85 | |
500 | 70.4±10.5 | 42.45 | |
Solvent+S9 | 20.5±2.4 |
(b) Acute toxicity test of passive smoking and observation of pulmonary histopathology of mice
Reaction of mice during the test is detailed in the following. The mouse smoking No.1 cigarette is excited and active for the first ten cigarettes and then quiet. In the process of smoking, its ears, mouth, toes and tail are subject to hyperemia, and it scurries about and twitches before death. But the mouse smoking No.2 cigarette has longer quiet time, delayed death and calm breath, while hyperemia of its ears, mouth, nose, throat, toes and tail is less obvious than that of the mouse smoking No.1. Survival rate, median lethal dose and lethal dose for the cigarette with the invented filter tip are higher than those of the blank control cigarette, and smoke toxicity of the former also reduces. (Table 3).
Groups | Number of tested mice | Survival rate (%) | Median lethal dose(cig) | Lethal dose(cig) |
No.1 | 60 | 33.3 | 49 | 35 |
No.2 | 60 | 40.0 | 54 | 44 |
(c) Toxicity test of neutrophil erythrocyte
According to Table 4, median lethal dose of tar for No.1 and No.2 is 141.42µg/ml and 213.35µg/ml respectively, so cytotoxicity of tar in the invented filter tip is much lower than that of the blank control group.
Groups | Median lethal dose (LD50,µg/ml) |
No.1 | 141.42 |
No.2 | 213.35 |
(d) Subchronic toxicity test
The rats are weighted by balance respectively after passive smoking for 30 days. Three groups, including the negative control, are not found obvious weight changes and not reach the significance level. Then rats are killed to obtain their respiratory tract and lung for pathology observation. It is found that periacinar emphysema of rats smoking No.1 cigarette is serious while that smoking No. 2 cigarette is mild. Sternum marrow of rats, whose blood samples are taken, is collected for micronucleus test, and the test results are shown in the Table 5. The tar-induced micronucleus frequency of the blank control group, No. 1 Group and No.2 Group is 2.33‰, 5.00‰ and 3.92‰ respectively. Compared with the blank control, the positive result is reached, but there is no significant difference between No.1 and No.2. That is to say, no new toxicity and side effects appear after the biological composition is added into the filter tip which can alleviate injury of lung to a certain degree.
Groups | Number of Cell observed | Number of micronuclei | Micronuclear rates (‰) |
Blank group (negative control) | 12000 | 28 | 2.33 |
No.1 | 12000 | 60 | 5.00 |
No.2 | 12000 | 47 | 3.92 |
Claims (9)
- A type of composite filter tips containing biological composition, which is characterized in that the biological composition adheres to a carrier, which is added to the tow filter rod when the rod is made, and the biological composition consists of cobalt porphyrin and ginkgo leaf extract.
- A type of composite filter tips containing biological composition according to Claim 1, which is characterized in that it is the dual composite filter which is made from the tow filter rod with biological composition and the tow filter rod without biological composition.
- A type of composite filter tips containing biological composition according to Claim 1, which is characterized in that mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼80; ratio of mass of the biological composition to the carrier is 0.1‰∼5.0‰; the addition of the carrier with biological composition in the tow filter rod is 3-30mg/cigarette.
- A type of composite filter tips containing biological composition according to Claim 3, which is characterized in that mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼50.
- A type of composite filter tips containing biological composition according to Claim 4, which is characterized in that mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:0∼10.
- A method of preparing the composite filter tip containing biological composition, including the following steps:(1) The biological composition of cobalt porphyrin and ginkgo leaf extract is prepared and dissolved in ethanol. In addition, a polyvinylpyrrolidone is added to the ethanol solution containing biological composition and mixed up.(2) The mixture in Step (1) adheres to the carrier.(3) The carrier in Step (2) is added evenly when tow filter rod is made.(4) Then the tow filter rod with the composition and one without the composition are rolled with the inner coil paper respectively(5) Finally, tow filter rods are made into the filter tip with outer coil paper on the composite filter tip maker.
- A method of preparing the composite filter tip according to Claim 6, which is characterized in that the biological composition consists of cobalt porphyrin and ginkgo leaf extract; mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼80; mass ratio of the biological composition to the carrier is 0.1‰∼5.0‰; the addition of the carrier with biological composition in the tow filter rod is 3-30mg/cigarette.
- A method of preparing the composite filter tip according to Claim 7, which is characterized in that mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼10.
- A composite filter tip containing biological composition according to Claims 1-8 is applied to a cigarette.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102635484A CN101708072B (en) | 2009-12-23 | 2009-12-23 | Composite filter tip containing biological composition |
PCT/CN2010/071732 WO2011075970A1 (en) | 2009-12-23 | 2010-04-13 | Composite filter comprising biological composition |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2517584A1 EP2517584A1 (en) | 2012-10-31 |
EP2517584A4 EP2517584A4 (en) | 2013-12-25 |
EP2517584B1 true EP2517584B1 (en) | 2015-09-02 |
Family
ID=42400898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10838536.0A Active EP2517584B1 (en) | 2009-12-23 | 2010-04-13 | Composite filter comprising biological composition |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2517584B1 (en) |
CN (1) | CN101708072B (en) |
WO (1) | WO2011075970A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105167190A (en) * | 2015-06-17 | 2015-12-23 | 湖北中烟工业有限责任公司 | Finely cut tobacco leaves with flavone essence for cigarettes and method for preparing finely cut tobacco leaves |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102715654B (en) * | 2012-06-15 | 2014-02-26 | 川渝中烟工业有限责任公司 | Filter additive for reducing nitrosamines in cigarette smoke and application of filter additive |
CN102697183B (en) * | 2012-06-15 | 2014-02-26 | 川渝中烟工业有限责任公司 | Cigarette filter additive with harm reduction effect and preparation method and application thereof |
CN104026732B (en) * | 2014-06-13 | 2017-01-04 | 广西中烟工业有限责任公司 | The preparation method of a kind of Nicotiana tabacum L. glutinous rice flour composite particles and the flavouring application in filter tip thereof |
CN108013505A (en) * | 2017-12-06 | 2018-05-11 | 湖北中烟工业有限责任公司 | A kind of method of bionical ferroheme and synthesis and preparation containing the bionical ferroheme mouth rod |
CN108576921B (en) * | 2018-03-21 | 2021-02-02 | 云南中烟工业有限责任公司 | Composite material for reducing phenol release amount in smoke and preparation method and application thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5746231A (en) * | 1993-01-11 | 1998-05-05 | Craig Lesser | Tobacco smoke filter for removing toxic compounds |
US5909736A (en) * | 1994-06-27 | 1999-06-08 | Stavridis; Ioannis | Removal of noxious oxidants and carcinogenic volatile nitrosocompounds from cigarette smoke using biological substances |
CN1080548C (en) * | 1999-11-23 | 2002-03-13 | 郭灿城 | Biological tobacco tar reducing agent |
DE10009829A1 (en) * | 2000-03-01 | 2001-09-20 | Reemtsma H F & Ph | Filter cigarette has two part filter with ventilator, core, casing and length of tobacco. |
KR20030010166A (en) * | 2001-07-25 | 2003-02-05 | 조주환 | A filtering material for cigarette and its process to use ginkgo leaf ingredients |
ITMI20012756A1 (en) * | 2001-12-21 | 2003-06-21 | Filtrona Italia S P A | FILTERS FOR CIGARETTES CONTAINING LIPOPHILIC FLAVONOIDS AND / OR TOCOPHEROLS AND TOCOTRIENOLS |
CN1650763A (en) * | 2005-02-24 | 2005-08-10 | 冷博 | Tar harm reducing type cigarette and its preparation method |
CN100431435C (en) * | 2005-10-26 | 2008-11-12 | 重庆烟草工业有限责任公司 | Use of four kinds of porphyrin compounds to remove carcinogenic substances from smoke of cigarette |
MX2007004566A (en) * | 2006-04-17 | 2009-02-16 | Filligent Ltd | Method and device for making tobacco smoke filters. |
CN2909862Y (en) * | 2006-05-15 | 2007-06-13 | 牡丹江卷烟材料厂有限责任公司 | Two-element composite filter-tip made of paper, active carbon and acetate fiber |
-
2009
- 2009-12-23 CN CN2009102635484A patent/CN101708072B/en active Active
-
2010
- 2010-04-13 WO PCT/CN2010/071732 patent/WO2011075970A1/en active Application Filing
- 2010-04-13 EP EP10838536.0A patent/EP2517584B1/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105167190A (en) * | 2015-06-17 | 2015-12-23 | 湖北中烟工业有限责任公司 | Finely cut tobacco leaves with flavone essence for cigarettes and method for preparing finely cut tobacco leaves |
CN105167190B (en) * | 2015-06-17 | 2018-10-09 | 湖北中烟工业有限责任公司 | Cigarette is with flavones essence cigarette pearl and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
EP2517584A4 (en) | 2013-12-25 |
EP2517584A1 (en) | 2012-10-31 |
WO2011075970A1 (en) | 2011-06-30 |
CN101708072B (en) | 2011-04-13 |
CN101708072A (en) | 2010-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2517584B1 (en) | Composite filter comprising biological composition | |
US7025067B2 (en) | Activated charcoal filter for effectively reducing p-benzosemiquinone from the mainstream cigarette smoke | |
JP5161585B2 (en) | Cigarette with filter | |
JP5832991B2 (en) | Cigarette filter | |
JP4963338B2 (en) | Cigarette smoke element and method for manufacturing the same | |
CN111035057A (en) | Method for preparing tar extract from waste cigarette butts and application of tar extract in cigarettes | |
KR100964503B1 (en) | Cucurbituril added cigarettes and manufacturing method thereof | |
Rathkamp et al. | Chemical Studies on Tobacco Smoke: XX: Smoke Analysis of Cigarettes made from Bright Tobaccos Differing in Variety and Stalk Positions | |
CN101858042A (en) | Cigarette forming paper functional paint for selectively reducing harmful substances such as phenol and the like in smoke gas | |
KR20220124691A (en) | Method for producing tar extract with aroma-generating properties using discarded cigarette butts and application thereof in cigarettes | |
EP4245745A1 (en) | Tobacco extract containing cembratriendiol and production method therefor | |
CN202514579U (en) | Cigarette filter | |
CN106083781B (en) | A kind of benzo lactone preparation method and applications with cigarette flavouring effect | |
CN102433793A (en) | Flavoring method for filter rod wrapping paper | |
EP2937001A1 (en) | Aluminosilicate sab-15 as an additive for reducing the toxic and carcinogenic compounds present in tobacco smoke | |
RU91815U1 (en) | FILTER FOR CIGARETTES | |
CN115894499B (en) | Novel natural sulfur-containing alkaloid and preparation method and application thereof | |
CN111035053B (en) | Method for extracting aroma components from cigarette end tar and application of aroma components in cigarettes | |
CN103783661A (en) | Method for extracting tobacco essence and flavor from processing waste gas of cigarette factory | |
Jin et al. | Application of Triethyl Citrate to Filters in Virginia Type Cigarettes | |
CN116023334A (en) | Large-scale preparation method of natural alkaloids and application of natural alkaloids in removing harmful substances from cigarettes | |
CN113647675A (en) | Composite filter tip for adsorbing 2-butanone in cigarette smoke and cigarette | |
CN111567854A (en) | Benzisothiafuranolactone compound, preparation method thereof, antioxidant and additive containing benzisothiafuranolactone compound and application of benzisothiafuranolactone compound | |
CN113598411A (en) | Composite filter tip for adsorbing crotonaldehyde in cigarette smoke and cigarette | |
CN108272129A (en) | A kind of preparation method of the cigarette with protective effect on cancer risk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120202 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CHINA TOBACCO CHUANYU INDUSTRIAL CO., LTD |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A24B 15/20 20060101ALI20131108BHEP Ipc: A24D 3/02 20060101ALI20131108BHEP Ipc: A24D 3/06 20060101AFI20131108BHEP Ipc: A24B 15/28 20060101ALI20131108BHEP Ipc: A24B 15/16 20060101ALI20131108BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20131126 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A24B 15/20 20060101ALI20131119BHEP Ipc: A24B 15/28 20060101ALI20131119BHEP Ipc: A24B 15/16 20060101ALI20131119BHEP Ipc: A24D 3/06 20060101AFI20131119BHEP Ipc: A24D 3/02 20060101ALI20131119BHEP |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WANG, CHANGGUO Inventor name: DAI, YA |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20150330 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 745969 Country of ref document: AT Kind code of ref document: T Effective date: 20150915 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602010027274 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 745969 Country of ref document: AT Kind code of ref document: T Effective date: 20150902 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151202 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D Ref country code: NL Ref legal event code: MP Effective date: 20150902 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160102 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602010027274 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20150402567 Country of ref document: GR Effective date: 20160219 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20160603 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160430 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20160413 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160413 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20161230 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160430 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160430 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160502 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160413 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160413 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20100413 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160430 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150902 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602010027274 Country of ref document: DE Representative=s name: ROESLER-RASCH-VAN DER HEIDE & PARTNER PATENT- , DE |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20230517 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240701 Year of fee payment: 15 |